Quality of tuberculosis care in private health facilities of addis ababa, ethiopia.
Gezahegn GebrekidanGezahegn TesfayeMitiku Teshome HambisaNegussie DeyessaPublished in: Tuberculosis research and treatment (2014)
Ensuring provision of good quality tuberculosis (TB) care, especially in private for profit health facilities, is an important component of TB control strategy to reduce poor medical practice which results in multidrug resistant TB (MDR-TB). The aim of this study was to investigate quality of TB care in private health facilities of Addis Ababa. A facility based cross-sectional study was conducted based on Donabedian's structure-process-outcome model of health care quality. Quality of care was determined by adherence to National TB Program guidelines, treatment success rate, and client satisfaction. Exit interview was conducted on 292 patients on the intensive phase of treatment and 384 patient records were reviewed in eight private health facilities. Initial diagnostic AFB test was done for 95.4% of pulmonary TB patients. Most important components of TB care recommended by national guidelines were delivered for a significant proportion of patients. Majority (75%) of the clients were found to be satisfied with each component of TB care. The treatment success rate was 90.9%. The quality of TB care was fairly good. However, only 77.7% of the patients were counseled for HIV testing. Strengthening HIV counseling and testing, tackling shortage of streptomycin and laboratory reagent at private TB clinic is crucial.
Keyphrases
- healthcare
- quality improvement
- mycobacterium tuberculosis
- end stage renal disease
- palliative care
- ejection fraction
- hiv testing
- multidrug resistant
- public health
- prognostic factors
- chronic kidney disease
- emergency department
- men who have sex with men
- metabolic syndrome
- patient reported outcomes
- pain management
- peritoneal dialysis
- health information
- pulmonary hypertension
- antiretroviral therapy
- escherichia coli
- hiv positive
- drug induced
- affordable care act
- climate change
- patient reported
- acinetobacter baumannii
- replacement therapy